Chao Guan

Chao Guan

Auto-generated profile, based on publicly available information

Chao Guan

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
CGChao Guan
Chao Guan
XZXiaoye Zhang
Xiaoye Zhang
LYLi Yu
Li Yu
Brain metastasis from lung cancer is a prevalent mode of treatment failure associated with a poor prognosis. The incidence of brain metastasis has recently shown a dramatic increase. The early detection and risk stratification of lung cancer–related brain metastasis would be highly advantageous for patients. However, our current knowledge and comprehension of the underlying mechanisms driving brain metastasis in lung cancer pose significant challenges. This review summarizes the mechanisms underlying brain metastasis, focusing on the intricate interplay between lung cancer–derived tumor cells and the unique characteristics of the brain, recent advancements in the identification of driver genes, concomitant genes, epigenetic features, including miRNAs and long noncoding RNAs, as well as the molecular characterization of brain metastasis originating from other organs, which may further enhance risk stratification and facilitate precise treatment strategies.

17 June 2026
Verified
Other
Open access
CGChao Guan
Chao Guan
XZXiaoye Zhang
Xiaoye Zhang
LYLi Yu
Li Yu
Table S2 shows ncRNAs associated with lung cancer BM.

17 June 2026
Verified
Other
Open access
CGChao Guan
Chao Guan
XZXiaoye Zhang
Xiaoye Zhang
LYLi Yu
Li Yu
Figure S1 shows factors contributing to EGFR mutation predisposition to BM in lung cancer.

2 May 2024
Verified
Other
Open access
CGChao Guan
Chao Guan
XZXiaoye Zhang
Xiaoye Zhang
LYLi Yu
Li Yu
Brain metastasis from lung cancer is a prevalent mode of treatment failure associated with a poor prognosis. The incidence of brain metastasis has recently shown a dramatic increase. The early detection and risk stratification of lung cancer–related brain metastasis would be highly advantageous for patients. However, our current knowledge and comprehension of the underlying mechanisms driving brain metastasis in lung cancer pose significant challenges. This review summarizes the mechanisms underlying brain metastasis, focusing on the intricate interplay between lung cancer–derived tumor cells and the unique characteristics of the brain, recent advancements in the identification of driver genes, concomitant genes, epigenetic features, including miRNAs and long noncoding RNAs, as well as the molecular characterization of brain metastasis originating from other organs, which may further enhance risk stratification and facilitate precise treatment strategies.

2 May 2024
Verified
Other
Open access
PDF file
CGChao Guan
Chao Guan
XZXiaoye Zhang
Xiaoye Zhang
LYLi Yu
Li Yu
Figure S1 shows factors contributing to EGFR mutation predisposition to BM in lung cancer.

2 May 2024
Verified
Other
Open access
CGChao Guan
Chao Guan
XZXiaoye Zhang
Xiaoye Zhang
LYLi Yu
Li Yu
Table S1 shows EGFR co-mutated genes associated with lung cancer BM.